35 results
424B7
BHVN
Biohaven Ltd.
16 Aug 24
Prospectus with selling stockholder info
4:31pm
and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. We are advancing our innovative
424B5
BHVN
Biohaven Ltd.
16 Aug 24
Prospectus supplement for primary offering
4:21pm
our innovative portfolio of therapeutics, leveraging our proven drug development experience and multiple, proprietary drug development platforms
8-K
EX-99.1
BHVN
Biohaven Ltd.
8 Aug 24
Biohaven Reports Second Quarter 2024 Financial Results and Recent Business Developments
4:17pm
-1300, a first-in-human IgG degrader from its innovative MoDE platform. Results from the initial dose cohorts in the SAD study confirmed that BHV-1300 … of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. The company is advancing its innovative portfolio
424B7
BHVN
Biohaven Ltd.
17 May 24
Prospectus with selling stockholder info
4:41pm
immunology, neuroscience, and oncology. We are advancing our innovative portfolio of therapeutics, leveraging our proven drug development experience
8-K
EX-99.1
haha5
9 May 24
Biohaven Reports First Quarter 2024 Financial Results and Recent Business Developments
4:14pm
424B5
8mef99z
19 Apr 24
Prospectus supplement for primary offering
6:02am
424B5
wlo quznwvnn6f9
17 Apr 24
Prospectus supplement for primary offering
4:01pm
8-K
EX-99.1
10i sc6garbvmjv0c
15 Apr 24
Regulation FD Disclosure
6:59am
424B7
a336x0 uzp
12 Mar 24
Prospectus with selling stockholder info
4:37pm
8-K
EX-99.1
tw9ki6vg01924m9zi97e
29 Feb 24
Biohaven Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Developments
4:16pm
8-K
EX-99.1
rpdzkjbdl 1u3
8 Jan 24
Regulation FD Disclosure
7:30am
8-K
EX-99.1
zytkclrbmg uw
14 Nov 23
Biohaven Reports Third Quarter 2023 Financial Results and Recent Business Developments
4:26pm
8-K
EX-99.1
rpkwpj
27 Sep 23
Regulation FD Disclosure
6:58am
8-K
EX-99.1
l6dzv7m n7y7l4v8
12 May 23
Biohaven Reports First Quarter 2023 Financial Results and Reports Recent Business Developments
4:47pm